Toxicity and quality of life report of a phase II study of stereotactic body radiotherapy (SBRT) for low and intermediate risk prostate cancer

BACKGROUND: Clinical data indicates that delivery of larger daily doses of radiation may improve the therapeutic ratio for prostate cancer compared to conventional fractionation. A phase II study of stereotactic body radiotherapy with real-time motion management and daily plan re-optimization for lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyer, Matthew J., Papagikos, Michael A., Kiteley, Rex, Vujaskovic, Zeljko, Wu, Jackie, Lee, W. Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237336/
https://www.ncbi.nlm.nih.gov/pubmed/28086825
http://dx.doi.org/10.1186/s13014-016-0758-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237336/
https://www.ncbi.nlm.nih.gov/pubmed/28086825
http://dx.doi.org/10.1186/s13014-016-0758-8

Ejemplares similares